New 2026 research links endometriosis to elevated ovarian and breast cancer risks. Here's what the science says and what ...
Durvalumab monotherapy did not meet the prespecified statistical threshold for DFS versus active monitoring, despite a 6-point absolute 3-year DFS difference (78% vs 72%). RAMPART enrolled ...
BACKGROUND: Bisphenol F (BPF) is a common substitute for bisphenol A and the most prevalent bisphenol compound in diverse ...
Simon May - Senior VP and President of Life Sciences & Diagnostics Markets Group Mike Zhang - Senior VP & President of Applied Markets Group Thank you, Karina, and welcome, everyone, to Agilent's ...
Background Acute inflammatory responses during and after percutaneous coronary intervention (PCI) are associated with subsequent cardiovascular event risk, but limited data exist on acute immune cell ...
frontMIND randomized 899 adults (IPI 3–5; ECOG 0–2) to six 21-day cycles of tafasitamab/lenalidomide/R-CHOP vs placebo/R-CHOP, with investigator-assessed PFS as ...
mNational Institute for Health Research National Commercial Research Delivery Centre, Bradford, UK nNational Institute for Health Research Manchester Biomedical Research Centre, Manchester University ...
Halting the insidious accumulation of irreversible disability remains the principal challenge in multiple sclerosis care. Once classified as relapsing (including relapsing-remitting and active ...